Jordi Ochando, PhD
img_Jordi Ochando
ASSISTANT PROFESSOR | Oncological Sciences
ASSISTANT PROFESSOR | Medicine, Nephrology
Research Topics
Cancer, Dendritic Cells, Growth, Immunological Tolerance, Transplantation
Multi-Disciplinary Training Area
Immunology [IMM]

BSc, University of Alicante

PhD, De Montfort University


Selected Publications

VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe. Jon Salmanton-García, Pauline Wipfler, Paula Valle-Simón, Christina Merakou, Ioannis Kopsidas, Ullrich Bethe, Angela Steinbach, Orly Spivak, Lenka Součková, Maria Amélia Mendonça, Markela Koniordou, Margot Hellemans, Jesus Frías-Iniesta, Ruth Joanna Davis, Imre Barta, Anna Maria Azzini, Helena H. Askling, Christos D. Argyropoulos, Elena Álvarez-Barco, Murat Akova, Marc M.J. Bonten, Miriam Cohen-Kandli, Rebecca Jane Cox, Robert Flisiak, Petr Husa, Ligita Jancoriene, Alena Koscalova, Odile Launay, Jens Lundgren, Patrick Mallon, Laura Marques, Pontus Nauclér, Jordi Ochando, Zoi Dorothea Pana, Evelina Tacconelli, Krisztina Tóth, Sven Trelle, Pierre van Damme, Theoklis E. Zaoutis, Markus Zeitlinger, Kerstin Albus, Fiona A. Stewart, Sanne H.I. Hofstraat, Patricia Bruijning-Verhagen, Oliver A. Cornely. Vaccine

Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis. Javier Arranz-Herrero, Jesús Presa, Sergio Rius-Rocabert, Alberto Utrero-Rico, José Ángel Arranz-Arija, Antonio Lalueza, María M. Escribese, Jordi Ochando, Vicente Soriano, Estanislao Nistal-Villan. International Journal of Infectious Diseases

Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination. Maria Gonzalez-Perez, Jana Baranda, Marcos J. Berges-Buxeda, Patricia Conde, Mayte Pérez-Olmeda, Daniel Lozano-Ojalvo, Carmen Cámara, Maria del Rosario Llópez-Carratalá, Emilio Gonzalez-Parra, Pilar Portolés, Alberto Ortiz, Jose Portoles, Jordi Ochando. Pharmaceuticals

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Ochando during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Company Founder:

  • Trained Therapeutix Discovery (TTxD)

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • TTxD

Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose

  • Instituto de Salud Carlos III

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.